Multimodal Imaging-Guided Photothermal Immunotherapy Based on a Versatile NIR-II Aggregation-Induced Emission Luminogen

Angew Chem Int Ed Engl. 2022 Jul 4;61(27):e202202614. doi: 10.1002/anie.202202614. Epub 2022 May 5.

Abstract

Synergistic photothermal immunotherapy has captured great attention owing to the mutually strengthening therapeutic outcomes towards both original tumors and abscopal tumors. Herein, a versatile theranostic agent displaying aggregation-induced emission, namely TPA-BT-DPTQ, was designed and prepared based on benzo[c]thiophene unit as a building block; it can be used for simultaneous fluorescence imaging (FLI) in the second near-infrared (NIR-II) window, photoacoustic imaging (PAI), photothermal imaging (PTI), and thermal eradication of tumors. Further experiments validate that photothermal therapy (PTT) mediated by TPA-BT-DPTQ nanoparticles not only destroys the primary tumor but also enhances immunogenicity for further suppressing the growth of tumors at distant sites. Furthermore, PTT combining a programmed death-ligand 1 (PD-L1) antibody prevents the metastasis and recurrence of cancer by potentiating the effect of immunotherapy.

Keywords: Aggregation-Induced Emission; Immunogenic Cell Death; Immunotherapy; NIR-II Emission; Photothermal Therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line, Tumor
  • Humans
  • Immunotherapy
  • Multimodal Imaging
  • Nanoparticles* / therapeutic use
  • Neoplasms* / diagnostic imaging
  • Neoplasms* / pathology
  • Neoplasms* / therapy
  • Photoacoustic Techniques* / methods
  • Phototherapy / methods
  • Theranostic Nanomedicine / methods